# FDA 483 - Blood Connection, Inc. (The) - May 27, 2025

Source: https://www.keypedia.com/records/483/blood-connection-inc-the/7e68c544-ac6e-4e94-b324-6858eb596c9c

> FDA 483 for Blood Connection, Inc. (The) on May 27, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Blood Connection, Inc. (The)
- Inspection Date: 2025-05-27
- Product Type: biologics
- Office Name: Atlanta District Office
- Summary: The Blood Connection, Inc. in Morrisville, NC, a blood bank, was cited for significant deficiencies during an FDA inspection. Observations included a failure to consistently follow written standard operating procedures for handling returned blood and blood components. Additionally, the firm failed to conduct thorough investigations into unexplained discrepancies, specifically regarding potential contamination of returned platelet units.

## Related Documents

- [483 - 2019-08-16](https://www.keypedia.com/records/483/blood-connection-inc-the/64a485a0-c684-4c88-86d8-29389012846d)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/david-e-lowe/1a2492c2-4a81-4486-b3af-37f6b7b5216a)
- [Marla A. Cassidy](https://www.keypedia.com/people/marla-a-cassidy/d2859ca5-e77b-4385-9a96-4c785f3ac4c6)

Company: https://www.keypedia.com/companies/blood-connection-inc-the/c049c660-43f3-4747-9f5c-4e62d8c5a92d

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7